Inducible expression of the signal transduction protein 14-3-3γ in injured arteries and stimulated human vascular smooth muscle cells

Experimental and Molecular Pathology

Volumn 76, Issue 2, 2004, Pages 99-107

  Autieri, Michael V ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

14 3 3; Arterial injury; Cytokines; Restenosis; Smooth muscle cell

Indexed keywords

CYTOKINE; ISOPROTEIN; PROTEIN 14 3 3;

ANIMAL MODEL; ANIMAL TISSUE; AORTA MEDIA; ARTICLE; CELL ACTIVATION; CELL CULTURE; CELL STIMULATION; CONTROLLED STUDY; CORONARY ARTERY DISEASE; EXPERIMENTAL ANIMAL; HEART FAILURE; HEART TRANSPLANTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; ISOLATED ARTERY; NONHUMAN; NUCLEOTIDE SEQUENCE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN PROTEIN INTERACTION; RAT; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; SWINE; VASCULAR SMOOTH MUSCLE;

14-3-3 PROTEINS; ANIMALS; AORTA; BLOTTING, NORTHERN; BLOTTING, WESTERN; CELLS, CULTURED; CORONARY ARTERIOSCLEROSIS; CORONARY VESSELS; DISEASE MODELS, ANIMAL; HEART FAILURE, CONGESTIVE; HUMANS; IMMUNOHISTOCHEMISTRY; MUSCLE, SMOOTH, VASCULAR; RATS; SIGNAL TRANSDUCTION; SWINE; TYROSINE 3-MONOOXYGENASE;

SUS SCROFA;

EID: 1542328881     PISSN: 00144800     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexmp.2003.11.001     Document Type: Article

References (32)

1. Adam L.P., Franklin M.T., Raff G.J., Hathaway D.R. Activation of mitogen-activated protein kinase in porcine carotid arteries. Circ. Res. 76:1995;183-190.
2. Aitken A., Collinge D.B., van Heusden B., Isobe T., Rosenboom P.H. 14-3-3 Proteins: a highly conserved, widespread family of eukaryotic proteins. TIBS. 17:1992;498-501.
3. Austin G.E., Ratliff N.B., Hollman J., Tabei S., Phillips D.F. Intimal proliferation of smooth muscle cells as an explanation for recurrent coronary artery stenosis after percutaneous transluminal coronary angioplasty. J. Am. Coll. Cardiol. 6:1985;369-375.
4. Autieri M.V., Carbone C. 14-3-3γ interacts with and is phosphorylated by multiple PKC isoforms in PDGF-stimulated human vascular smooth muscle cells. DNA Cell Biol. 18:1999;555-564.
5. Autieri M.V., Haines D.S., Romanic A.M., Ohlstein E.H. Expression of 14-3-3γ in injured arteries and growth factor and cytokine-stimulated human vascular smooth muscle cells. Cell Growth Differ. 7:1996;1453-1460.
6. Autieri M.V., Mu A., Carbone C. Expression of allograft inflammatory factor-1 (AIF1) is a marker of activated human VSMC and arterial injury. Arterioscler., Thromb., Vasc. Biol. 20:2000;1737-1744.
7. Barinaga M. New clues to how protein link up to run the cell. Science. 283:1999;1247-1249.
8. Bilder G.et al. Restenosis following angioplasty in the swine coronary artery is inhibited by an oral active PDGF-receptor tyrosine kinase inhibitor, RPR101511A. Circulation. 99:1999;3292-3299.
9. Fantl W.J., Muslin A.J., Kikuchi A., Martin J.A., MacMicol A.M., Gross R.W., Williams L.T. Activation of raf-1 by 14-3-3 proteins. Nature. 371:1994;612-614.
10. Shc and its association with 14-3-3 protein in glomerular mesangial cells. J. Biol. Chem. 276:2001;26640-26647.
11. Freed E., Symons M., MacDonald S.G., McCormick F., Ruggieri R. Binding of 14-3-3 proteins to the protein kinase raf and effects on its activation. Science. 265:1994;1713-1716.
12. Hansson G.K., Holm J., Holm S., Fotev Z., Hedrich H.J., Fingerle J. T lymphocytes inhibit the vascular response to injury. Proc. Natl. Acad. Sci. U.S.A. 88:1991;10530-10534.
13. Herbert J.M., Clowes M., Lea H.J., Pascal M., Clowes A.W. Protein kinase C alpha expression is required for heparin inhibition of smooth muscle cell proliferation in ivitro and in vivo. J. Biol. Chem. 271:1996;25928-25935.
14. Hu Y., Cheng L., Hochleitner B.W., Xu Q. Activation of mitogen-activated protein kinases (ERK/JNK) and AP-1 transcription factor in rat carotid arteries after balloon injury. Arterioscler., Thromb., Vasc. Biol. 17:1997;2808-2816.
15. Inui H., Kitami M., Tani T., Kondo T., Inagami T. Differences in signal transduction between platelet-derived growth factor (PDGF) α and β receptors in vascular smooth muscle cells: PDGF-BB is a potent mitogen, but PDGF-AA promotes only protein synthesis without activation of DNA synthesis. J. Biol. Chem. 269:1994;30456-30552.
16. Ip J., Fuster V., Badimon L., Badimon J., Taubman M., Chesebro J. Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation. J. Am. Coll. Cardiol. 15:1990;1667-1687.
17. Isik F.F., McDonald T.O., Ferguson M., Yamanaka E., Gordon D. Transplant arteriosclerosis in a rat aortic model. Am. J. Pathol. 141:1992;1139-1149.
18. James T.W., Wagner R., White L.A., Zwolak R.M., Brinckerhoff C.E. Induction of collagenase and stromelysin gene expression by mechanical injury in a vascular smooth muscle-derived cell line. J. Cell. Physiol. 157:1993;426-437.
19. Kim S., Izumi Y., Yano M., Hamaguchi A., Miura K., Yamanaka A., Miyazaki H., Iwao H. Angiotensin blockade inhibits activation of mitogen-activated protein kinases in rat balloon-injured artery. Circulation. 97:1998;1731-1737.
20. Koyama H., Olson N.E., Dastvan F.F., Reidy M.A. Cell replication in the arterial wall. Activation of signaling pathway following in vivo injury. Circ. Res. 82:1998;713-721.
21. Labarrere C.A. Anticoagulation factors as predictors of transplant-associated coronary artery disease. J. Heart Lung Transplant. 19:2000;623-633.
22. Labarrere C.A., Pitts D., Nelson D.R., Fulk W.P. Vascular tissue plasminogen activator and the development of coronary artery disease in heart transplant recipients. N. Engl. J. Med. 333:1995;1111-1116.
23. Mennander A., Tiisala S., Halttunen J., Yilmaz S., Paavonen T., Hayry Chronic rejection in rat aortic allografts. An experimental model for transplant arteriosclerosis. Arterioscler. Thromb. 11:1991;671-680.
24. Morrison D. 14-3-3: Modulators of signalling proteins? Science. 266:1994;56-57.
25. Muslin A.J., Tanner J.W., Allen P.M., Shaw A.S. Interaction of 14-3-3 with signaling proteins is mediated by the recognition of phosphoserine. Cell. 84:1996;889-897.
26. Pyles J.M., March K.L., Franklin M., Mehdi K., Wilensky R.L., Adam L.P. Activation of MAP kinase in vivo follows balloon overstretch injury of porcine coronary and carotic arteries. Circ. Res. 81:1997;904-910.
27. Roberts T.M. A signal chain of events. Nature. 360:1995;534-535.
28. Rolfe B.E., Campbell J.H., Smith N.J., Cheong M.W., Campbell G.R. T lymphocytes affect smooth muscle cell phenotype and proliferation. Arterioscler., Thromb., Vasc. Biol. 15:1995;1204-1210.
29. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 362:1993;801-809.
30. Toker A., Sellers L.A., Amess B., Patel Y., Harris A., Aitken A. Multiple isoforms of a protein kinase C inhibitor (KCIP-1/14-3-3) from sheep brain: amino acid sequence of phosphorylated forms. Eur. J. Biochem. 206:1992;453-461.
31. Ventura H.O., Mehra M.R., Smart F.W. Cardiac allograft vasculopathy: current concepts. Am. Heart J. 129:1995;791-798.
32. Wang W., Chen H.J., Giedd K.N., Schwartz A., Cannon P.J., Rabbani L.E. T-cell lymphokines, interleukin-4, and gamma interferon, modulate the induction of vascular smooth muscle tissue plasminogen activator and migration by serum and platelet-derived growth factor. Circ. Res. 77:1995;1095-1106.